Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Krystal Biotech (KRYS) over the last 4 years, with Q4 2025 value amounting to 0.3.

  • Krystal Biotech's Asset Utilization Ratio rose 605.51% to 0.3 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.3, marking a year-over-year increase of 605.51%. This contributed to the annual value of 0.33 for FY2025, which is 505.32% up from last year.
  • Per Krystal Biotech's latest filing, its Asset Utilization Ratio stood at 0.3 for Q4 2025, which was up 605.51% from 0.31 recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Asset Utilization Ratio ranged from a high of 0.32 in Q2 2025 and a low of 0.0 during Q4 2021
  • In the last 4 years, Krystal Biotech's Asset Utilization Ratio had a median value of 0.25 in 2024 and averaged 0.2.
  • In the last 5 years, Krystal Biotech's Asset Utilization Ratio soared by 209108.55% in 2024 and then skyrocketed by 605.51% in 2025.
  • Quarter analysis of 4 years shows Krystal Biotech's Asset Utilization Ratio stood at 0.0 in 2021, then surged by 2375.81% to 0.06 in 2023, then soared by 352.34% to 0.29 in 2024, then grew by 6.06% to 0.3 in 2025.
  • Its last three reported values are 0.3 in Q4 2025, 0.31 for Q3 2025, and 0.32 during Q2 2025.